|
Volumn 7, Issue 9, 2006, Pages 710-
|
Sipuleucel-T shows partial advantage in prostate cancer.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER VACCINE;
SIPULEUCEL T;
SIPULEUCEL-T;
TISSUE EXTRACT;
ARTICLE;
CLINICAL TRIAL;
DISEASE COURSE;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
MALE;
PROSTATE TUMOR;
SURVIVAL RATE;
CANCER VACCINES;
CLINICAL TRIALS;
DISEASE PROGRESSION;
HUMANS;
IMMUNOTHERAPY;
MALE;
PROSTATIC NEOPLASMS;
SURVIVAL RATE;
TISSUE EXTRACTS;
|
EID: 33750112585
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(06)70846-4 Document Type: Article |
Times cited : (7)
|
References (0)
|